UPMC

Pittsburgh, PA 15206
Booth(s):  651

About

As an organization dedicated to Life Changing Medicine, UPMC has defined a bold mission: to shape the future of health care through innovation. This mission is brought to life through its UPMC Enterprises division, which focuses on turning innovative ideas into growing, thriving businesses. The team at UPMC Enterprises partners with colleagues across UPMC as well as with scientists at the University of Pittsburgh, health care entrepreneurs, and companies in all stages of commercial development to bring to market new health care companies, technologies, and solutions.

Press Releases

PITTSBURGH, Sept. 13, 2016 – UPMC and Cavulus, a software and services company serving the health insurance industry, announced today that they have formed a strategic partnership in which UPMC will invest in Cavulus and provide insights and development assistance for the growth of its cloud-based technology. Serving more than 35 health plans across the country, including UPMC Health Plan, Cavulus’ solutions help insurance companies automate marketing, sales, enrollment, retention and compliance operations, primarily in the Medicare Advantage market. Boosted by Cavulus’ predictive modeling and data analytics tools, the company’s clients have grown membership 20 percent faster than the Medicare Advantage industry average over the past five years. “We share UPMC’s vision of consumer-centered, affordable health care, driven by innovation and technology,” said Patrick Phillips, chief executive officer of 10-year-old Cavulus. “As a strategic partner and customer, UPMC will provide Cavulus with the expertise that we need to expand our products and services, particularly to meet the needs of the Health Insurance Exchange market.” The UPMC Health Plan has been a Cavulus customer for three years to support member acquisition for its Medicare Advantage business, which now has more than 134,000 members. “We continue to be impressed with the extensive knowledge that the Cavulus team brings to the table in a complex, highly regulated and very competitive business,” said Mary Beth Jenkins, senior vice president and chief operating officer for the UPMC Health Plan. “We’re excited about the opportunity to co-develop new functionality for this technology.” Cavulus expects to rapidly extend its product, creating a truly end-to-end solution for targeting, acquiring, managing and retaining health insurance customers. “Like other partners of UPMC Enterprises, Cavulus can accelerate its growth and reduce its risks by working closely with one of the nation’s leading integrated health care delivery and financing systems,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC that led the agreement. “This is the kind of strategic partnership that few other health care investors can match.”

San Mateo, Calif., March 23, 2015 - Health Fidelity, a company that develops innovative technologies for the value-based healthcare era, today announced that UPMC, one of the nation’s leading healthcare systems, has made a significant investment in the company.

UPMC identified the value of using a comprehensive risk adjustment solution for Medicare Advantage, Medicare ACO and health insurance exchange programs and then partnered in 2014 with Health Fidelity to complete development of this technology. The Health Fidelity risk adjustment solution, deployed at UPMC Health Plan last year, significantly enhances operational efficiency and compliance management. With UPMC’s strategic investment in the company, Health Fidelity is accelerating the introduction of risk adjustment and other value-based care solutions to the market.

As the healthcare ecosystem shifts from a fee-for-service to a value-based business model, healthcare organizations are looking for ways to optimize risk adjustment operations and improve compliance. Health Fidelity helps integrated delivery systems, health plans and health systems perfect the risk adjustment cycle by applying technologies that improve and complement existing systems and processes. Today, most of these organizations are making population management decisions using only 20% to 30% of available clinical information because of the challenges involved in interpreting and applying unstructured data. Health Fidelity provides solutions that leverage previously untapped data, which empowers organizations to streamline revenue operations, achieve higher levels of compliance and realize greater efficiencies.

“By collaborating with the clinical and technology experts at UPMC, Health Fidelity is able to offer the most comprehensive, scalable solution on the market for perfecting the risk adjustment cycle,” said Mary Beth Jenkins, Senior Vice President and Chief Operating Officer, UPMC Health Plan and UPMC WorkPartners. “It’s an innovative technology that has delivered measurable results to UPMC Health Plan, seamlessly integrating with existing risk adjustment processes to deliver results while improving compliance and process efficiencies.”

The simplicity of Health Fidelity’s solution is especially attractive to organizations that are looking to reduce the complexity of risk adjustment operations. The solution is designed to efficiently enhance retrospective and prospective analyses with an intuitive workflow that integrates disparate tasks into more streamlined, collaborative processes. Using cutting-edge natural language processing (NLP) technology, the solution maximizes client value by continuously improving the risk adjustment cycle.

UPMC, a national leader in the innovative use of technology, evaluated options and selected Health Fidelity as a partner due to its expertise in NLP and analytics. UPMC is now collaborating with Health Fidelity to innovate on additional use cases that will improve healthcare delivery and population management.

Health Fidelity plans to use the cash infusion to expand research and development, strengthen its team and increase the company’s market share. Health Fidelity will assess potential partnerships with additional investors, integrated delivery systems, health plans and health systems at the upcoming RISE Conference. To learn more about Health Fidelity and its groundbreaking value-based care solutions, please visit www.healthfidelity.com.

About UPMC
A world-renowned health care provider and insurer, Pittsburgh-based UPMC is inventing new models of accountable, cost-effective, patient-centered care. It provides more than $887 million a year in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution. The largest nongovernmental employer in Pennsylvania, UPMC integrates more than 60,000 employees, more than 20 hospitals, more than 500 doctors’ offices and outpatient sites, a more than 2.5-million-member health insurance division, and international and commercial operations. Affiliated with the University of Pittsburgh Schools of the Health Sciences, UPMC ranks No. 12 in the prestigious U.S. News & World Report annual Honor Roll of America’s Best Hospitals — and No. 1 in Pennsylvania. For more information, go to UPMC.com.

###

February 10, 2016— San Francisco, CA — Lantern, the leader in evidence-based online mental health wellness services, today announced the close of a $17 million investment led by Pittsburgh-based healthcare giant UPMC. The investment reflects a commitment from Lantern and UPMC to transform the way emotional wellbeing services are delivered and accessed in the U.S. UPMC was joined by all previous Lantern investors, including Mayfield Fund, SoftTech Venture Capital and Stanford University.
  As a leading mental health provider and research organization, UPMC will partner with Lantern to leverage its platform within a myriad of clinical settings and conditions. 

“We are excited about reaching more people with behavioral health issues through this readily accessible, scalable, and cost-effective platform,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC, which spearheaded this investment. “This partnership is an excellent example of our mission at UPMC Enterprises: finding creative solutions and technologies to solve some of the most challenging problems in healthcare.”

UPMC, one of the largest integrated healthcare delivery systems in the U.S., is “the ideal partner,” said Alejandro Foung, Lantern co-founder and CEO. “UPMC has a unique view into the continuum of care, from insuring more than 2.8 million individuals, to administering care preventatively and when patients need it most through its more than 20 hospitals and 3,500 employed physicians,” said Foung. “A large part of UPMC’s appeal to Lantern is its focus on disease prevention, a sharp contrast to the fee-for-service model that currently dominates the behavioral health landscape. Because of our shared focus on prevention to solve health challenges before they even arise or manifest, Lantern and UPMC are the perfect match.” 

Behavioral health problems are among the most pressing health issues facing the country, affecting more than 18 percent of adults. Depression and anxiety disorders are among the top five drivers of medical costs in primary care settings—and are even more common and costly among those with chronic medical conditions. Given the shortage of mental health workers, two-thirds of primary care physicians report difficulty referring patients to behavioral health services.

UPMC clinicians will work with Lantern on pilots aimed at expanding its programs to additional behavioral health issues and potentially to populations of patients with more complex conditions. “Integrating behavioral health into broader medical care and focusing on prevention for large groups of patients is the only way that we can deliver high-quality, cost-effective mental healthcare,” said Eva Szigethy, M.D., Ph.D., associate professor of psychiatry, pediatrics, and medicine at University of Pittsburgh School of Medicine, who will be working closely with the Lantern team.

The largest nongovernmental employer in Pennsylvania, UPMC integrates 60,000 employees, more than 20 hospitals, more than 500 doctors’ offices and outpatient sites, a health insurance division, and international and commercial operations. Affiliated with the University of Pittsburgh Schools of the Health Sciences, UPMC ranks No. 13 in the prestigious U.S. News & World Report annual Honor Roll of America’s Best Hospitals.

Building on UPMC’s 20-year track record of successful commercialization activity, UPMC Enterprises is dedicated to creating exceptional healthcare innovations that will have a measurable impact on the cost and quality of care. By partnering with innovators like Lantern, UPMC Enterprises is focused on creating and commercializing solutions in four key areas: clinical tools that will transform the delivery of care, population health management that will be essential in health care’s move from volume to value, consumer-centric healthcare, and business services that improve efficiency. 
PORTLAND, ME, Oct. 5, 2016 – RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.  Founded in 2011, RxAnte’s technology and clinical services enable its clients to improve clinical care quality and avoid unnecessary costs. The investment by UPMC Enterprises will facilitate product development in collaboration with clinical experts at UPMC and accelerate growth. RxAnte currently manages medication use for nearly 7 million people on behalf of health insurers, providers and other stakeholders confronting the urgent challenge of improving safe and effective prescription drug use. “This is a major milestone for RxAnte that will expand the breadth and depth of the analytics and population health management solutions we provide,” said Josh Benner, founder and chief executive officer of RxAnte. “We are very excited to partner with UPMC in our ongoing quest to solve the challenges of under-use, over-use and mis-use of prescription drugs.” RxAnte’s priorities with this new investment include expanding its offerings for Medicare, Medicaid and commercial populations, with particular focus on analytics and clinical programs that lower total cost of care. The company also intends to extend its predictive models and workflow tools to the management of high-cost specialty drugs. “Improving medication use is increasingly recognized as one of the biggest but most challenging opportunities to improve patient outcomes while reducing health care costs,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC that led this partnership. “With its deep understanding of the predictive power of data and suite of tools for using data to change behavior, RxAnte is key to our strategy of developing and deploying smart technology to address the toughest challenges in health care.” For the UPMC Health Plan, a customer of RxAnte for the past three years, the company’s solutions have optimized medication use, saving excess medical costs and directly contributing to the plan’s superior Star Rating performance on medication adherence measures by the Centers for Medicare & Medicaid Services. “RxAnte’s technology and services have been a key driver of our stellar performance in ensuring that our members receive the appropriate medications for their conditions, leading to better patient outcomes and effective cost management,” said William H. Shrank, M.D., chief medical officer for the UPMC Insurance Services Division. “With UPMC’s clinical expertise and the Health Plan’s strength in analytics, we look forward to supporting RxAnte’s product development and advancing our joint goal of providing the highest value from prescription medications.”
PITTSBURGH and PLANO, TEXAS, Feb. 25, 2016 – UPMC, a leading, integrated health care provider and insurer, is partnering with Vivify Health as a customer of and investor in its mobile population health solutions to remotely care for patients. Vivify Health’s technology is used by the nation’s largest health organizations, representing more than 500 hospitals and payers, to efficiently manage, monitor and engage patient populations of all sizes and risk levels. Founded in 2009, Vivify was the first company to offer a Cloud-based solution for mobile population health and chronic care management using any consumer mobile device. “After an extensive evaluation of a number of companies, Vivify Health clearly stood out to us as the one best aligned to deliver patient-centered remote care across UPMC’s integrated payer/provider system,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC which led the Vivify investment. “As we deliver care under an increasingly risk-based reimbursement model, we are excited to become a customer, development partner and investor in Vivify’s scalable population health management technology. Backing this kind of innovation to solve critical health care problems is at the heart of our mission at UPMC Enterprises.” Uniquely positioned for true population health management Vivify Health solutions enable insurance and provider organizations to conduct virtual care visits, communicate seamlessly with patients and members, and remotely monitor any patient population, such as those with chronic illnesses. The solutions are tailored to patients of all levels of technology expertise, from an “instant-on” health kit for consumers with limited or no technology experience, to a bring-your-own-device (BYOD) solution for those who prefer to use their own devices, such as smartphones and tablets. “Vivify’s remote monitoring and communication technology is essential to making patients true partners in their care and providing the right services when and where they need them, increasingly at home,” said Andrew Watson, M.D., UPMC’s medical director of telemedicine and vice president of UPMC International. “As an integrated health care delivery and financing system, we are focused on keeping patients well and out of the hospital, and that can happen only with affordable, easy-to-use technology like Vivify's.” Such flexibility to conform to the consumer’s unique needs and comfort level has contributed to outcomes that Vivify reports with other customers, such as reducing readmissions by 65 percent, improving return on investment by 144 percent and achieving patient compliance and satisfaction rates well over 95 percent. UPMC joins growing roster of customer investors Vivify Health’s other investors include several of the nation’s largest health systems and health plans, including over 700 hospitals represented by Heritage Group and Ascension Ventures, followed by LabCorp and Envision Health. As day-to-day users, customer-investors like UPMC take an active role in the continued development of the Vivify Health platform and the company’s strategic direction. To that end, Brenton Burns, executive vice president of UPMC Enterprises, will join the Vivify Health board of directors. Enterprises’ experienced product development team in Pittsburgh also will work with Vivify to enhance its solutions and to deploy them effectively across UPMC’s vast system which covers virtually every aspect of care, including not only hospitals and physician offices, but rehabilitation and senior living facilities.  “We are honored to partner with UPMC, one of the nation’s most prestigious health systems, to advance its mission to provide outstanding patient care and shape tomorrow’s health care with innovative population health technology,” said Eric Rock, Vivify Health CEO. “We look forward to helping UPMC achieve unprecedented outcomes for its patients as part of its commitment to patient-centered, affordable care.”

Xealth, a digital health care startup, today announced an $8.5M investment led by DFJ and the launch of its digital prescribing and analytics platform. The Xealth platform, which is being used by two of the largest health care systems in the US—Seattle-based Providence and Pittsburgh-based UPMC—enables physicians and clinicians to prescribe customized digital health care content, apps, and services as easily as they do medications today.

The emergence of digital health technologies has given rise to more empowered patients and a renewed focus on their health care experience. More than 90 percent of patients say they would use physician-prescribed apps and services to help manage their chronic condition. However, tools that allow clinicians to recommend digital solutions have not kept pace with patients’ desire to use them. Moreover, clinicians have little visibility into a patient's engagement with and adherence to these prescribed solutions.

With Xealth, clinicians can prescribe and track the use of educational health content, apps for disease management, and devices to help monitor care, all from their electronic medical record (EMR) charting interface. Xealth aggregates and filters a variety of content sources in a care provider's existing EMR workflow within Epic, simplifying the ability to create a customized experience for the patient. Clinicians can discuss these digital health tools with their patients during appointments, track usage afterward, and schedule reminders to ensure patients use them. Patients can access these digital health prescriptions from their current health system’s secure patient portal online, such as Epic's MyChart.

The technology was launched at Providence to support two initial use cases. In primary care, physicians can prescribe educational video content from ACP Decisions to engage patients in the discussion around advance care planning. In women’s health, Xealth works with Circle, another digital service developed by Providence to provide personalized physician-led support for moms from pregnancy to pediatrics.

"Xealth will dramatically improve the connection between patients and clinicians," said Rod Hochman, M.D., President and CEO, Providence St. Joseph Health. "Xealth extends the patient and physician relationship outside the walls of a traditional care setting by making it easy for clinicians to prescribe digital content, services, and apps for their patients."

"Xealth represents how technology can help patients and physicians work together toward better health," said Tal Heppenstall, President of UPMC Enterprises, the innovation and commercialization arm of UPMC. "Xealth can accelerate the development and adoption of health care solutions throughout our more than 25 hospitals and 500-plus outpatient sites in a scalable, consistent manner, while helping our physicians engage patients more effectively."

Xealth was incubated within Providence's Digital Innovation Group and is the first technology spinout from the program. Mike McSherry, co-founder of Swype, a predictive text technology sold to Nuance in 2011, and several Swype team members joined Providence last year as executives-in-residence to find new innovations in health care. McSherry and team founded Xealth as a result.

"Providence and UPMC are our ideal launch partners, given their size and focus on the next generation of health care," said McSherry. "Together, we'll be able to better measure the impact of our more engaged patients on their health outcomes, and the effectiveness of prescribing content, apps, and services. We're inspired by the possibility of this platform and its potential to become and industry-wide solution."

Providence, UPMC, Hennepin Healthcare System, Froedtert Health and other health systems anticipate expanding the use of the Xealth platform to more easily integrate, prescribe, and monitor a variety of third-party digital solutions. These applications span patient education (articles and video), apps (oncology care, diabetes prevention), and connected medical devices (CPAP machines). As provider systems continue to move more to preventative services, continuous care, remote monitoring and timely interventions, the Xealth platform will help teams provide better patient care.

About Xealth

Xealth was founded in 2016 by serial entrepreneurs who have successfully created and sold multiple companies—most recently Swype, a mobile keyboard deployed on billions of phones. Incubated at Providence Health & Services through its Digital Innovation Group, the Xealth platform enables clinicians to prescribe and monitor digital health care content, apps, and services as easily as they do medications or orders today. Xealth can onboard new digital care vendors in a fraction of the time, integrate the patient experience into a health system portal, and determine the efficacy and engagement of digital care solutions across patient populations.

PITTSBURGH and PLANO, TEXAS, Feb. 25, 2016 – UPMC, a leading, integrated health care provider and insurer, is partnering with Vivify Health as a customer of and investor in its mobile population health solutions to remotely care for patients. Vivify Health’s technology is used by the nation’s largest health organizations, representing more than 500 hospitals and payers, to efficiently manage, monitor and engage patient populations of all sizes and risk levels. Founded in 2009, Vivify was the first company to offer a Cloud-based solution for mobile population health and chronic care management using any consumer mobile device. “After an extensive evaluation of a number of companies, Vivify Health clearly stood out to us as the one best aligned to deliver patient-centered remote care across UPMC’s integrated payer/provider system,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC which led the Vivify investment. “As we deliver care under an increasingly risk-based reimbursement model, we are excited to become a customer, development partner and investor in Vivify’s scalable population health management technology. Backing this kind of innovation to solve critical health care problems is at the heart of our mission at UPMC Enterprises.” Uniquely positioned for true population health management Vivify Health solutions enable insurance and provider organizations to conduct virtual care visits, communicate seamlessly with patients and members, and remotely monitor any patient population, such as those with chronic illnesses. The solutions are tailored to patients of all levels of technology expertise, from an “instant-on” health kit for consumers with limited or no technology experience, to a bring-your-own-device (BYOD) solution for those who prefer to use their own devices, such as smartphones and tablets. “Vivify’s remote monitoring and communication technology is essential to making patients true partners in their care and providing the right services when and where they need them, increasingly at home,” said Andrew Watson, M.D., UPMC’s medical director of telemedicine and vice president of UPMC International. “As an integrated health care delivery and financing system, we are focused on keeping patients well and out of the hospital, and that can happen only with affordable, easy-to-use technology like Vivify's.” Such flexibility to conform to the consumer’s unique needs and comfort level has contributed to outcomes that Vivify reports with other customers, such as reducing readmissions by 65 percent, improving return on investment by 144 percent and achieving patient compliance and satisfaction rates well over 95 percent. UPMC joins growing roster of customer investors Vivify Health’s other investors include several of the nation’s largest health systems and health plans, including over 700 hospitals represented by Heritage Group and Ascension Ventures, followed by LabCorp and Envision Health. As day-to-day users, customer-investors like UPMC take an active role in the continued development of the Vivify Health platform and the company’s strategic direction. To that end, Brenton Burns, executive vice president of UPMC Enterprises, will join the Vivify Health board of directors. Enterprises’ experienced product development team in Pittsburgh also will work with Vivify to enhance its solutions and to deploy them effectively across UPMC’s vast system which covers virtually every aspect of care, including not only hospitals and physician offices, but rehabilitation and senior living facilities.  “We are honored to partner with UPMC, one of the nation’s most prestigious health systems, to advance its mission to provide outstanding patient care and shape tomorrow’s health care with innovative population health technology,” said Eric Rock, Vivify Health CEO. “We look forward to helping UPMC achieve unprecedented outcomes for its patients as part of its commitment to patient-centered, affordable care.”

San Mateo, Calif., March 23, 2015 - Health Fidelity, a company that develops innovative technologies for the value-based healthcare era, today announced that UPMC, one of the nation’s leading healthcare systems, has made a significant investment in the company.

UPMC identified the value of using a comprehensive risk adjustment solution for Medicare Advantage, Medicare ACO and health insurance exchange programs and then partnered in 2014 with Health Fidelity to complete development of this technology. The Health Fidelity risk adjustment solution, deployed at UPMC Health Plan last year, significantly enhances operational efficiency and compliance management. With UPMC’s strategic investment in the company, Health Fidelity is accelerating the introduction of risk adjustment and other value-based care solutions to the market.

As the healthcare ecosystem shifts from a fee-for-service to a value-based business model, healthcare organizations are looking for ways to optimize risk adjustment operations and improve compliance. Health Fidelity helps integrated delivery systems, health plans and health systems perfect the risk adjustment cycle by applying technologies that improve and complement existing systems and processes. Today, most of these organizations are making population management decisions using only 20% to 30% of available clinical information because of the challenges involved in interpreting and applying unstructured data. Health Fidelity provides solutions that leverage previously untapped data, which empowers organizations to streamline revenue operations, achieve higher levels of compliance and realize greater efficiencies.

“By collaborating with the clinical and technology experts at UPMC, Health Fidelity is able to offer the most comprehensive, scalable solution on the market for perfecting the risk adjustment cycle,” said Mary Beth Jenkins, Senior Vice President and Chief Operating Officer, UPMC Health Plan and UPMC WorkPartners. “It’s an innovative technology that has delivered measurable results to UPMC Health Plan, seamlessly integrating with existing risk adjustment processes to deliver results while improving compliance and process efficiencies.”

The simplicity of Health Fidelity’s solution is especially attractive to organizations that are looking to reduce the complexity of risk adjustment operations. The solution is designed to efficiently enhance retrospective and prospective analyses with an intuitive workflow that integrates disparate tasks into more streamlined, collaborative processes. Using cutting-edge natural language processing (NLP) technology, the solution maximizes client value by continuously improving the risk adjustment cycle.

UPMC, a national leader in the innovative use of technology, evaluated options and selected Health Fidelity as a partner due to its expertise in NLP and analytics. UPMC is now collaborating with Health Fidelity to innovate on additional use cases that will improve healthcare delivery and population management.

Health Fidelity plans to use the cash infusion to expand research and development, strengthen its team and increase the company’s market share. Health Fidelity will assess potential partnerships with additional investors, integrated delivery systems, health plans and health systems at the upcoming RISE Conference. To learn more about Health Fidelity and its groundbreaking value-based care solutions, please visit www.healthfidelity.com.

About UPMC
A world-renowned health care provider and insurer, Pittsburgh-based UPMC is inventing new models of accountable, cost-effective, patient-centered care. It provides more than $887 million a year in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution. The largest nongovernmental employer in Pennsylvania, UPMC integrates more than 60,000 employees, more than 20 hospitals, more than 500 doctors’ offices and outpatient sites, a more than 2.5-million-member health insurance division, and international and commercial operations. Affiliated with the University of Pittsburgh Schools of the Health Sciences, UPMC ranks No. 12 in the prestigious U.S. News & World Report annual Honor Roll of America’s Best Hospitals — and No. 1 in Pennsylvania. For more information, go to UPMC.com.

###

PORTLAND, ME, Oct. 5, 2016 – RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.  Founded in 2011, RxAnte’s technology and clinical services enable its clients to improve clinical care quality and avoid unnecessary costs. The investment by UPMC Enterprises will facilitate product development in collaboration with clinical experts at UPMC and accelerate growth. RxAnte currently manages medication use for nearly 7 million people on behalf of health insurers, providers and other stakeholders confronting the urgent challenge of improving safe and effective prescription drug use. “This is a major milestone for RxAnte that will expand the breadth and depth of the analytics and population health management solutions we provide,” said Josh Benner, founder and chief executive officer of RxAnte. “We are very excited to partner with UPMC in our ongoing quest to solve the challenges of under-use, over-use and mis-use of prescription drugs.” RxAnte’s priorities with this new investment include expanding its offerings for Medicare, Medicaid and commercial populations, with particular focus on analytics and clinical programs that lower total cost of care. The company also intends to extend its predictive models and workflow tools to the management of high-cost specialty drugs. “Improving medication use is increasingly recognized as one of the biggest but most challenging opportunities to improve patient outcomes while reducing health care costs,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC that led this partnership. “With its deep understanding of the predictive power of data and suite of tools for using data to change behavior, RxAnte is key to our strategy of developing and deploying smart technology to address the toughest challenges in health care.” For the UPMC Health Plan, a customer of RxAnte for the past three years, the company’s solutions have optimized medication use, saving excess medical costs and directly contributing to the plan’s superior Star Rating performance on medication adherence measures by the Centers for Medicare & Medicaid Services. “RxAnte’s technology and services have been a key driver of our stellar performance in ensuring that our members receive the appropriate medications for their conditions, leading to better patient outcomes and effective cost management,” said William H. Shrank, M.D., chief medical officer for the UPMC Insurance Services Division. “With UPMC’s clinical expertise and the Health Plan’s strength in analytics, we look forward to supporting RxAnte’s product development and advancing our joint goal of providing the highest value from prescription medications.”
February 10, 2016— San Francisco, CA — Lantern, the leader in evidence-based online mental health wellness services, today announced the close of a $17 million investment led by Pittsburgh-based healthcare giant UPMC. The investment reflects a commitment from Lantern and UPMC to transform the way emotional wellbeing services are delivered and accessed in the U.S. UPMC was joined by all previous Lantern investors, including Mayfield Fund, SoftTech Venture Capital and Stanford University.
  As a leading mental health provider and research organization, UPMC will partner with Lantern to leverage its platform within a myriad of clinical settings and conditions. 

“We are excited about reaching more people with behavioral health issues through this readily accessible, scalable, and cost-effective platform,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC, which spearheaded this investment. “This partnership is an excellent example of our mission at UPMC Enterprises: finding creative solutions and technologies to solve some of the most challenging problems in healthcare.”

UPMC, one of the largest integrated healthcare delivery systems in the U.S., is “the ideal partner,” said Alejandro Foung, Lantern co-founder and CEO. “UPMC has a unique view into the continuum of care, from insuring more than 2.8 million individuals, to administering care preventatively and when patients need it most through its more than 20 hospitals and 3,500 employed physicians,” said Foung. “A large part of UPMC’s appeal to Lantern is its focus on disease prevention, a sharp contrast to the fee-for-service model that currently dominates the behavioral health landscape. Because of our shared focus on prevention to solve health challenges before they even arise or manifest, Lantern and UPMC are the perfect match.” 

Behavioral health problems are among the most pressing health issues facing the country, affecting more than 18 percent of adults. Depression and anxiety disorders are among the top five drivers of medical costs in primary care settings—and are even more common and costly among those with chronic medical conditions. Given the shortage of mental health workers, two-thirds of primary care physicians report difficulty referring patients to behavioral health services.

UPMC clinicians will work with Lantern on pilots aimed at expanding its programs to additional behavioral health issues and potentially to populations of patients with more complex conditions. “Integrating behavioral health into broader medical care and focusing on prevention for large groups of patients is the only way that we can deliver high-quality, cost-effective mental healthcare,” said Eva Szigethy, M.D., Ph.D., associate professor of psychiatry, pediatrics, and medicine at University of Pittsburgh School of Medicine, who will be working closely with the Lantern team.

The largest nongovernmental employer in Pennsylvania, UPMC integrates 60,000 employees, more than 20 hospitals, more than 500 doctors’ offices and outpatient sites, a health insurance division, and international and commercial operations. Affiliated with the University of Pittsburgh Schools of the Health Sciences, UPMC ranks No. 13 in the prestigious U.S. News & World Report annual Honor Roll of America’s Best Hospitals.

Building on UPMC’s 20-year track record of successful commercialization activity, UPMC Enterprises is dedicated to creating exceptional healthcare innovations that will have a measurable impact on the cost and quality of care. By partnering with innovators like Lantern, UPMC Enterprises is focused on creating and commercializing solutions in four key areas: clinical tools that will transform the delivery of care, population health management that will be essential in health care’s move from volume to value, consumer-centric healthcare, and business services that improve efficiency. 
PITTSBURGH, Sept. 13, 2016 – UPMC and Cavulus, a software and services company serving the health insurance industry, announced today that they have formed a strategic partnership in which UPMC will invest in Cavulus and provide insights and development assistance for the growth of its cloud-based technology. Serving more than 35 health plans across the country, including UPMC Health Plan, Cavulus’ solutions help insurance companies automate marketing, sales, enrollment, retention and compliance operations, primarily in the Medicare Advantage market. Boosted by Cavulus’ predictive modeling and data analytics tools, the company’s clients have grown membership 20 percent faster than the Medicare Advantage industry average over the past five years. “We share UPMC’s vision of consumer-centered, affordable health care, driven by innovation and technology,” said Patrick Phillips, chief executive officer of 10-year-old Cavulus. “As a strategic partner and customer, UPMC will provide Cavulus with the expertise that we need to expand our products and services, particularly to meet the needs of the Health Insurance Exchange market.” The UPMC Health Plan has been a Cavulus customer for three years to support member acquisition for its Medicare Advantage business, which now has more than 134,000 members. “We continue to be impressed with the extensive knowledge that the Cavulus team brings to the table in a complex, highly regulated and very competitive business,” said Mary Beth Jenkins, senior vice president and chief operating officer for the UPMC Health Plan. “We’re excited about the opportunity to co-develop new functionality for this technology.” Cavulus expects to rapidly extend its product, creating a truly end-to-end solution for targeting, acquiring, managing and retaining health insurance customers. “Like other partners of UPMC Enterprises, Cavulus can accelerate its growth and reduce its risks by working closely with one of the nation’s leading integrated health care delivery and financing systems,” said Tal Heppenstall, president of UPMC Enterprises, the commercialization arm of UPMC that led the agreement. “This is the kind of strategic partnership that few other health care investors can match.”

WHERE THE WORLD
CONNECTS FOR HEALTH